DK2355812T3 - Nedbringelse af cirkulerende oxidiseret lavdensitet lipoprotein-beta-2-glycoprotein 1-kompleks til behandling af åreforkalkning - Google Patents

Nedbringelse af cirkulerende oxidiseret lavdensitet lipoprotein-beta-2-glycoprotein 1-kompleks til behandling af åreforkalkning Download PDF

Info

Publication number
DK2355812T3
DK2355812T3 DK09825826.2T DK09825826T DK2355812T3 DK 2355812 T3 DK2355812 T3 DK 2355812T3 DK 09825826 T DK09825826 T DK 09825826T DK 2355812 T3 DK2355812 T3 DK 2355812T3
Authority
DK
Denmark
Prior art keywords
glycoprotein
beta
treat
complex
reduction
Prior art date
Application number
DK09825826.2T
Other languages
Danish (da)
English (en)
Inventor
Bomi P Framroze
Original Assignee
Bomi P Framroze
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomi P Framroze filed Critical Bomi P Framroze
Application granted granted Critical
Publication of DK2355812T3 publication Critical patent/DK2355812T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK09825826.2T 2008-11-14 2009-11-10 Nedbringelse af cirkulerende oxidiseret lavdensitet lipoprotein-beta-2-glycoprotein 1-kompleks til behandling af åreforkalkning DK2355812T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11482308P 2008-11-14 2008-11-14
PCT/IB2009/007669 WO2010055419A2 (en) 2008-11-14 2009-11-10 A method of lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis

Publications (1)

Publication Number Publication Date
DK2355812T3 true DK2355812T3 (da) 2019-10-07

Family

ID=42170470

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09825826.2T DK2355812T3 (da) 2008-11-14 2009-11-10 Nedbringelse af cirkulerende oxidiseret lavdensitet lipoprotein-beta-2-glycoprotein 1-kompleks til behandling af åreforkalkning

Country Status (11)

Country Link
US (1) US9446013B2 (enExample)
EP (1) EP2355812B1 (enExample)
JP (2) JP2012508791A (enExample)
KR (1) KR20110098909A (enExample)
CN (1) CN102202661A (enExample)
AU (1) AU2009315314B2 (enExample)
BR (1) BRPI0915247A2 (enExample)
CA (1) CA2743434C (enExample)
DK (1) DK2355812T3 (enExample)
MX (1) MX2011005077A (enExample)
WO (1) WO2010055419A2 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952000B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events
US9119826B2 (en) 2011-02-16 2015-09-01 Pivotal Therapeutics, Inc. Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels
US8715648B2 (en) 2011-02-16 2014-05-06 Pivotal Therapeutics Inc. Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics
US8951514B2 (en) 2011-02-16 2015-02-10 Pivotal Therapeutics Inc. Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels
NO344004B1 (en) * 2017-06-23 2019-08-12 Olivita As Combination of oils
WO2021080951A1 (en) * 2019-10-21 2021-04-29 President And Fellows Of Harvard College Compositions and methods for detection of oxidizable analytes

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
US4681893A (en) 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
GB2238476A (en) * 1989-11-04 1991-06-05 K T Lalvani Therapeutic aquatic animal and garlic products
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
IT1274734B (it) * 1994-08-25 1997-07-24 Prospa Bv Composizioni farmaceutiche contenenti acidi grassi poliinsaturi, loro esteri o sali, unitamente a vitamine o provitamine antiossidanti
US5578334A (en) * 1995-04-07 1996-11-26 Brandeis University Increasing the HDL level and the HDL/LDL ratio in human serum with fat blends
IT1277953B1 (it) * 1995-12-21 1997-11-12 Sigma Tau Ind Farmaceuti Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
DE19855426A1 (de) * 1998-12-02 2000-06-08 Wolfgang Langhoff Mittel zur Therapie und Prophylaxe von rheumatisch-arthritischen Erkrankungen und zur Prophylaxe von cardiovaskulären Erkrankungen
JP2001346517A (ja) * 2000-06-02 2001-12-18 K-Tac Planners Co Ltd 食用油脂。
DE20105126U1 (de) * 2001-03-23 2002-01-31 Bartz, Volker, 35440 Linden Fischöl zur oralen Einnahme
GB0210212D0 (en) * 2002-05-03 2002-06-12 Univ Southampton Effects of dietary N-3 and N-6 pufa intake on atheromatous plaque stability
EP1501493B1 (en) * 2002-05-03 2009-10-07 Pronova BioPharma Norge AS Use of epa and dha in secondary prevention of strokes
ES2254018B2 (es) * 2004-11-16 2009-01-01 Universidad Autonoma De Madrid Mezcla oleosa de ingredientes bioactivos naturales para la preparacion de un producto alimenticio enriquecido.
PT1876906E (pt) * 2005-04-29 2009-12-15 Vinorica S L Suplemento alimentar ou alimento funcional contendo uma combinação de óleos
US20090252853A1 (en) * 2005-11-30 2009-10-08 Angel Gil Hernandez Lipid Mixture and Use Thereof in the Preparation of a Product That Is Intended for Enteral or Oral Administration
PL1800675T4 (pl) * 2005-12-23 2012-02-29 Nutricia Nv Kompozycja zawierająca wielonienasycone kwasy tłuszczowe, białka, mangan, i/lub molibden oraz nukleozydy/nukleotydy do leczenia otępienia
JP5099808B2 (ja) * 2006-05-29 2012-12-19 独立行政法人農業・食品産業技術総合研究機構 脂質代謝改善用組成物
WO2008088415A1 (en) * 2006-10-18 2008-07-24 Reliant Pharmaceuticals, Inc. Omega-3 fatty acids for reduction of lp-pla2 levels
US20090270502A1 (en) * 2007-01-11 2009-10-29 Carotino Sdn. Bhd. Method for Lowering Risk of Cardiovascular Diseases

Also Published As

Publication number Publication date
WO2010055419A3 (en) 2010-09-10
US9446013B2 (en) 2016-09-20
WO2010055419A2 (en) 2010-05-20
EP2355812A2 (en) 2011-08-17
AU2009315314A1 (en) 2010-05-20
KR20110098909A (ko) 2011-09-02
CA2743434A1 (en) 2010-05-20
MX2011005077A (es) 2011-05-25
CN102202661A (zh) 2011-09-28
EP2355812B1 (en) 2019-07-10
CA2743434C (en) 2015-04-21
JP2012508791A (ja) 2012-04-12
US20110207821A1 (en) 2011-08-25
AU2009315314B2 (en) 2013-04-18
EP2355812A4 (en) 2012-04-18
JP2015091855A (ja) 2015-05-14
BRPI0915247A2 (pt) 2016-02-16

Similar Documents

Publication Publication Date Title
EP2430010A4 (en) OXIDATION OF FURFURAL COMPOUNDS
HRP20180718T1 (hr) Oligopeptidni spojevi i njihova upotreba
EP2068927A4 (en) PROCESS FOR REDUCING EOSINOPHILLE MIRROR
DK2483278T3 (da) Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer
SMP201000118B (it) Composto di ossimetilene arile e loro utilizzo
DK2198704T4 (da) Fremgangsmåde til fiskeopdræt til berigelse af vand med opløst oxygen
BRPI0920565A2 (pt) emulsão de óleo em água
BR112012020928A2 (pt) armadilha de água em linha
PL2797416T3 (pl) Podstawione związki benzaldehydowe i sposoby ich zastosowania do zwiększania natlenienia tkanek
HRP20190016T1 (hr) Heterociklički spojevi i njihova upotreba
BR112012001325A2 (pt) tratamento de distúrbios do fígado com inibidaores de pi3k
BRPI0815407A2 (pt) Composições e métodos para controlar nematódeos
EP2412362A4 (en) COMPOSITION OF A WATER EMULSION IN OIL
PL2807926T3 (pl) Sole i polimorfy związku tetracyklinowego
IL208004A (en) Compounds for reducing uric acid and uses thereof
BR112012004273A2 (pt) métodos e kits para estabilizar agentes oxidantes e sanitizar água
PL2240018T3 (pl) Kompozycja zawierająca środek przeciwbólowy i przeciwhistaminowy
EP2583663A4 (en) EMULSION COSMETIC PRODUCT OIL IN WATER FOR SKIN
DK2355812T3 (da) Nedbringelse af cirkulerende oxidiseret lavdensitet lipoprotein-beta-2-glycoprotein 1-kompleks til behandling af åreforkalkning
DK2120923T3 (da) Anvendelse af substituerede pyranonsyrederivater til behandling af det metaboliske syndrom
EP2516337A4 (en) ENHANCED DIGESTION OF BIOSOLIDS IN WASTEWATER
DK2345765T3 (da) Vandbesparende skive
EP2376908A4 (en) SIMULATION OF NORMAL FRESH THROMBOCYTES
DK2665793T3 (da) Azeotroplignende sammensætninger af trans-1,1,1,4,4,4-hexafluor-2-buten og vand
DK3446565T3 (da) Fremgangsmåder til behandling af antipsykotika-induceret vægtøgning